Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$113.24 - $131.95 $177 Million - $206 Million
1,560,558 Added 8951.23%
1,577,992 $208 Million
Q4 2023

Feb 09, 2024

SELL
$100.18 - $109.02 $5.9 Million - $6.42 Million
-58,867 Reduced 77.15%
17,434 $1.9 Million
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $7.86 Million - $8.72 Million
76,301 New
76,301 $7.86 Million
Q4 2022

Feb 10, 2023

BUY
$87.44 - $112.11 $10.9 Million - $14 Million
125,003 New
125,003 $13.9 Million
Q2 2022

Aug 12, 2022

SELL
$83.49 - $94.64 $4.58 Million - $5.19 Million
-54,861 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $4.03 Million - $4.52 Million
54,861 New
54,861 $4.5 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $129 Million - $162 Million
-1,788,807 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $75.9 Million - $83.4 Million
1,058,446 Added 144.92%
1,788,807 $134 Million
Q2 2021

Aug 16, 2021

BUY
$70.31 - $77.77 $51.4 Million - $56.8 Million
730,361 New
730,361 $56.8 Million
Q1 2021

May 17, 2021

SELL
$68.86 - $81.11 $5.9 Million - $6.94 Million
-85,616 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $6.14 Million - $6.82 Million
85,616 New
85,616 $7 Million
Q4 2019

Feb 14, 2020

SELL
$77.58 - $87.54 $2.12 Million - $2.39 Million
-27,330 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$76.08 - $82.93 $2.08 Million - $2.27 Million
27,330 New
27,330 $2.3 Million
Q1 2019

May 14, 2019

SELL
$69.58 - $79.36 $9.64 Million - $11 Million
-138,569 Closed
0 $0
Q4 2018

Feb 15, 2019

BUY
$65.24 - $75.71 $9.04 Million - $10.5 Million
138,569 New
138,569 $10.6 Million
Q1 2018

May 14, 2018

SELL
$50.96 - $59.23 $835,591 - $971,194
-16,397 Closed
0 $0
Q4 2017

Feb 12, 2018

BUY
$51.62 - $61.64 $846,413 - $1.01 Million
16,397
16,397 $922,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.